No your simply taking your past experience on Drop and trying to mold it into Future Healthcare to enhance your argument or somehow give it merits- some warrants contain clauses that if they were to offer warrants cheaper to someone else that they too would be eligible for the new cheaper pricing given to someone else to protect the banks interest or that if they defaulted on a loan it could change terms
So not only is your stock DROP off topic here its also a very far distant comparison to FUTU with an ultra clean balance sheet- DROP had over 32 million in accumulated deficit and was early on almost comparable to a cash poor pharmaceutical so the additional rounds of financings shouldn't be a surprise for anybody.
Not only is the conversion price .25 above todays market pricing the warrants are 50 cents so suggesting otherwise without proof is your conjured up gloom and doom that you may want but I know better